Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study
United States2,511 participantsStarted 2018-07-17
Plain-language summary
In this protocol, investigators are examining the ability for a novel multiplex PCR assay with mixed floral antibiotic resistance profiling is safe and increases effective treatment for urinary tract infections in a urology clinic over traditional culture methods alone and decreases retreatment rates in this population.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Patient Informed Consent form completed
* Male and Female Subjects may participate with no predetermined quotas or ratios for gender participation.
* All patients must be ≥60 years old. For patients presenting with a diagnosis of interstitial cystitis, patients may be of any age.
* Patients must be presenting for treatment of acute UTI, complicated UTI, persistent UTI, or recurrent UTI's.
* Including prostatitis, pyelonephritis, and/or interstitial cystitis.
* Data pertaining to the times at which the specimen samples are collected and stabilized needs to be documented.
* Specimen samples obtained need to have a sufficient volume necessary to perform a urine culture and Guidance 4.0.
Exclusion Criteria:
* • Do not provide written informed Consent with HIPAA authorization form.
* Taking antibiotics for any reason other than UTI at the time of enrollment
* Patients with chronic (\> 10 days) indwelling catheters
* Self-catheterized patients
* Patients with neobladders